author-photo

Stéphanie Gout

French Institute of Health and Medical Research

10

Papers

404

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

VEGF 165 b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop

2019 Oncogene
Show All
- Source
- Cite
- Save
Citations (25)
VEGF165b : un marqueur de réponse aux thérapies anti-angiogéniques dans les cancers du poumon ?

2014 Revue Des Maladies Respiratoires
Show All
- Source
- Cite
- Save
Citations (0)
204: Pre-mRNA alternative splicing controls VEGF-A autocrine functions and response to bevacizumab in non small cell lung carcinoma

2014 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
A new function of the splicing factor SRSF2 in the control of E2F1-mediated cell cycle progression in neuroendocrine lung tumors.

2013 Cell Cycle
Show All
- Source
- Cite
- Save
Citations (20)
Abnormal Expression of the Pre-mRNA Splicing Regulators SRSF1, SRSF2, SRPK1 and SRPK2 in Non Small Cell Lung Carcinoma

2012 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (99)
322 The VEGF-a Splice Variants VEGF155 and VEGF155b Differentially Control the Proliferation of Non Small Cell Lung Carcinoma Cells

2012 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
The Metastatic Process: An Overview

2010
Show All
- Source
- Cite
- Save
Citations (3)
The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo

2010 Oncogene
Show All
- Source
- Cite
- Save
Citations (72)
Death Receptor-3, a New E-Selectin Counter-Receptor that Confers Migration and Survival Advantages to Colon Carcinoma Cells by Triggering p38 and ERK MAPK Activation

2006 Cancer Research
Show All
- Source
- Cite
- Save
Citations (77)